A detailed history of Alpha Dna Investment Management LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 2,752 shares of TMDX stock, worth $209,262. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,752
Previous 3,436 19.91%
Holding current value
$209,262
Previous $517,000 16.44%
% of portfolio
0.17%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$135.68 - $176.11 $92,805 - $120,459
-684 Reduced 19.91%
2,752 $432,000
Q2 2024

Aug 14, 2024

SELL
$72.62 - $150.62 $239,718 - $497,196
-3,301 Reduced 49.0%
3,436 $517,000
Q1 2024

May 15, 2024

BUY
$70.86 - $89.93 $28,344 - $35,972
400 Added 6.31%
6,737 $498,000
Q4 2023

Feb 12, 2024

BUY
$36.74 - $81.08 $232,821 - $513,803
6,337 New
6,337 $500,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.42B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.